Literature DB >> 27139512

IgG4 deposits in pure and combined membranous lupus nephritis.

David Herrera van Oostdam1, Marco U Martínez Martínez1, Cuauhtémoc Oros-Ovalle1, David Martínez-Gala1, Gerardo T Jaimes Piñón1, Carlos Abud Mendoza2.   

Abstract

The aim of this study is to determine the frequency and prognosis of IgG4 deposits in renal biopsy of patients with membranous lupus nephritis (MLN). This is a retrospective cohort study in which we included patients with class V alone or combined (III/V or IV/V) of lupus nephritis according to the 2004 ISN/RPS. All the patients included must have availability of renal tissue for immunohistochemistry analyses. We excluded other classes of lupus nephritis. The renal tissue was examined by a nephro-pathologist. We included 65 patients with MLN; of these, 24 (37 %) were class V, and the other had proliferative concomitant with membranous patterns. Seven renal specimens had IgG4 deposits (10 %). Patients with IgG4 deposits had higher levels of eosinophils in serum. All of the patients with IgG4 had renal involvement as first manifestations of systemic lupus erythematosus. The rate of renal failure was 42 and 43 % in IgG4 positive and negative, respectively, 28 % of IgG4 required renal replacement therapy. From a histological view, 42 % of IgG4 had evidence of arteriolar vasculitis in renal biopsies. Lupus patients with IgG4 deposits were more likely to have renal involvement as a first manifestation of systemic lupus erythematosus, and they course with a worse prognosis since they required more dialysis. Also, they have more probability of vascular inflammation on the renal biopsy.

Entities:  

Keywords:  IgG4-related disease; Lupus; Membranous; Nephritis

Mesh:

Substances:

Year:  2016        PMID: 27139512     DOI: 10.1007/s10067-016-3276-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  Experimental Models of Membranous Nephropathy.

Authors:  J Ashley Jefferson; Jeffrey W Pippin; Stuart J Shankland
Journal:  Drug Discov Today Dis Models       Date:  2010

2.  Evaluation of clinical outcomes and renal vascular pathology among patients with lupus.

Authors:  Claire Barber; Andrew Herzenberg; Ellie Aghdassi; Jiandong Su; Wendy Lou; Gan Qian; Jonathan Yip; Samih H Nasr; David Thomas; James W Scholey; Joan Wither; Murray Urowitz; Dafna Gladman; Heather Reich; Paul R Fortin
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 8.237

Review 3.  Pathogenesis of membranous nephropathy: recent advances and future challenges.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

4.  IgG4- related disease as a rare cause of tubulointerstitial nephritis.

Authors:  Lennard Y W Lee; Hsiu Yap; Steve Sampson; Brian Ford; Grant Hayman; James Marsh; Amolak S Bansal
Journal:  J Clin Immunol       Date:  2014-05-01       Impact factor: 8.317

5.  Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo.

Authors:  D Vlahakos; M H Foster; A A Ucci; K J Barrett; S K Datta; M P Madaio
Journal:  J Am Soc Nephrol       Date:  1992-02       Impact factor: 10.121

Review 6.  True vasculitis in lupus nephritis.

Authors:  A A Abdellatif; S Waris; A Lakhani; H Kadikoy; W Haque; L D Truong
Journal:  Clin Nephrol       Date:  2010-08       Impact factor: 0.975

7.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

Review 8.  Immunosuppressive treatment of idiopathic membranous nephropathy: the dilemma continues.

Authors:  Edward J Filippone
Journal:  Clin Nephrol       Date:  2013-02       Impact factor: 0.975

9.  Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites.

Authors:  D V Vlahakos; M H Foster; S Adams; M Katz; A A Ucci; K J Barrett; S K Datta; M P Madaio
Journal:  Kidney Int       Date:  1992-06       Impact factor: 10.612

10.  Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?

Authors:  Lesley J Mason; Chelliah T Ravirajan; Anisur Rahman; Chaim Putterman; David A Isenberg
Journal:  Arthritis Rheum       Date:  2004-03
View more
  2 in total

1.  An Unexpected Kidney Biopsy Finding in a Patient with Newly Diagnosed SLE.

Authors:  Clarkson R Crane; Katayoon Shayan; Elizabeth Ingulli
Journal:  Kidney360       Date:  2021-09-30

2.  Concurrent IgG4-related tubulointerstitial nephritis and IgG4 myeloperoxidase-anti-neutrophil cytoplasmic antibody positive crescentic glomerulonephritis: A case report.

Authors:  Tao Su; Li Yang; Zhao Cui; Su-Xia Wang; Ming-Hui Zhao
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.